Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
The Journal of Rheumatology|October 9, 2007
Bone edema determined by magnetic resonance imaging reflects severe disease status in patients with early-stage rheumatoid arthritisMami Tamai, Atsushi Kawakami, Masataka Uetani, et al.
Modern Rheumatology|June 7, 2012
Significant improvement in MRI-proven bone edema is associated with protection from structural damage in very early RA patients managed using the tight control approachJunko Kita, Mami Tamai, Kazuhiko Arima, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 23, 2016
Clinical and Genetic Features of Patients With TNFRSF1A Variants in Japan: Findings of a Nationwide SurveyNaoyasu Ueda, Hiroaki Ida, Masakazu Washio, et al.
Arthritis Care & Research|November 17, 2010
Comparative study of the detection of joint injury in early-stage rheumatoid arthritis by magnetic resonance imaging of the wrist and finger joints and physical examinationMami Tamai, Atsushi Kawakami, Naoki Iwamoto, et al.
Modern Rheumatology|September 30, 2009
Prediction of DAS28-CRP remission in patients with rheumatoid arthritis treated with tacrolimus at 6 months by baseline variablesToshiyuki Aramaki, Atsushi Kawakami, Naoki Iwamoto, et al.
Modern Rheumatology|December 29, 2010
Reduction in serum levels of substance P in patients with rheumatoid arthritis by etanercept, a tumor necrosis factor inhibitorTomoki Origuchi, Naoki Iwamoto, Shin-ya Kawashiri, et al.
Plos One|February 26, 2013
The contribution of SAA1 polymorphisms to Familial Mediterranean fever susceptibility in the Japanese populationKiyoshi Migita, Kazunaga Agematsu, Junya Masumoto, et al.
Medicine|May 7, 2014
Familial Mediterranean fever: genotype-phenotype correlations in Japanese patientsKiyoshi Migita, Kazunaga Agematsu, Masahide Yazaki, et al.
Journal of Clinical Medicine|November 25, 2023
Periostin Is a Biomarker of Rheumatoid Arthritis-Associated Interstitial Lung DiseaseGoushi Matama, Masaki Okamoto, Kiminori Fujimoto, et al.
Modern Rheumatology|September 8, 2011
Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows an excellent effect in patients with very early rheumatoid arthritis with poor prognosis factorsJunko Kita, Mami Tamai, Kazuhiko Arima, et al.
Pageof 14